No Data
No Data
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
Phreesia (PHR) Improves Healthcare Outcomes and Expects Growing Clientele
JP Morgan Maintains Overweight on Phreesia, Raises Price Target to $28
Phreesia Analyst Ratings
J.P. Morgan Maintains Phreesia(PHR.US) With Buy Rating, Raises Target Price to $28
J.P. Morgan analyst Anne Samuel maintains $Phreesia(PHR.US)$ with a buy rating, and adjusts the target price from $27 to $28.According to TipRanks data, the analyst has a success rate of 51.0% and a
Truist Financial Maintains Phreesia(PHR.US) With Buy Rating, Announces Target Price $31
Truist Financial analyst Jailendra Singh maintains $Phreesia(PHR.US)$ with a buy rating, and sets the target price at $31.According to TipRanks data, the analyst has a success rate of 34.0% and a